New hope for OCD? experimental drug trial seeks to ease debilitating symptoms
NCT ID NCT07111988
Summary
This study is testing whether a medication called valbenazine can safely reduce symptoms in adults with moderate to severe obsessive-compulsive disorder (OCD). Thirty participants will take the drug or a placebo for six weeks each, with a break in between, to see which is more effective. The goal is to see if valbenazine can help people better manage their OCD symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBSESSIVE-COMPULSIVE DISORDER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.